New Ray Medicine International Holding Limited announced that Mr. Chu Xueping was appointed as an executive Director at the AGM with effect from 18 June 2021. Mr. Chu has over 10 years of experience in the pharmaceutical industry in the PRC. Mr. Chu was the deputy general manager of from 2011 to 2015 and the deputy president of Hainan Noken Pharmaceutical Co. Ltd.